Zepp Health
ZEPP
32 hedge funds and large institutions have $41.3M invested in Zepp Health in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 13 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
1.15% less ownership
Funds ownership: 50.27% → 49.11% (-1.2%)
12% less call options, than puts
Call options by funds: $934K | Put options by funds: $1.06M
16% less funds holding
Funds holding: 38 → 32 (-6)
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
57% less capital invested
Capital invested by funds: $96.2M → $41.3M (-$54.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.99M |
| 2 |
Goldman Sachs
New York
|
+$1.89M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
+$1.88M |
| 4 |
YCM
Yiheng Capital Management
San Francisco,
California
|
+$1.18M |
| 5 |
MM
Monolith Management
Hong Kong
|
+$823K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.77M |
| 2 |
TA
Trivest Advisors
Hong Kong
|
-$2.7M |
| 3 |
HFM
Harvest Fund Management
Beijing,
China
|
-$1.97M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.31M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$1.25M |
ZEPP Hedge Fund Activity: Q1 2026 in Review
32 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in Zepp Health (ZEPP) for Q1 2026, worth a combined $41.3M — down 57% from $96.2M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of ZEPP and 7 opened new positions — a net loss of 6 holders — while 10 trimmed existing stakes and 11 added.
The largest buyer was Morgan Stanley, adding an estimated $1.99M. The largest seller was Balyasny Asset Management, cutting an estimated $2.77M.
- 32 institutional investors held Zepp Health (ZEPP) as of Q1 2026, down from 38 in Q4 2025.
- Funds reported $41.3M of Zepp Health stock for Q1 2026, down 57% quarter-over-quarter.
- 7 funds opened new Zepp Health positions in Q1 2026 and 13 closed out, a net change of -6 holders.
- The largest Zepp Health buyer in Q1 2026 was Morgan Stanley, an estimated $1.99M added.
- The largest Zepp Health seller in Q1 2026 was Balyasny Asset Management, an estimated $2.77M sold.
Based on aggregated 13F filings for Q1 2026.